HBV Recurrence



Low Risk of HBV Recurrence after Liver Transplantation in Patients Maintained on Antiviral Therapy  11/03/06
Presence of Intrahepatic HBV DNA Does Not Predict Recurrence after Liver Transplantation  11/03/06

 






Google_______________


 

 

 

 

 

 

 

 

 

 

 

 

 

 


Conference
Main Page


Hepatitis C
FDA-Approved
Treatments

Monotherapies
Intron A
Roferon
Infergen
Pegasys
PEG-Intron


Combination
Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin

Hepatitis B
FDA-Approved
Treatments

Baraclude
Epivir-HBV
Hepsera
Intron A
Pegasys
Tyzeka